About Diagnostic BioSystems
Diagnostic BioSystems is a Healthcare company based in Pleasanton (United States) founded in 1994. Diagnostic BioSystems is engaged in providing immunohistochemistry solutions. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Its Indian entity Diagnostic Biosystems Usa Private Limited reported revenue of ₹5.77 Cr. Diagnostic BioSystems offers products and services including Primary Antibodies, Detection Systems, and Instrumentation. Its focus areas include Medical Devices and Diagnostic Equipment. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
Diagnostic BioSystems is involved in the development and distribution of innovative anatomic pathology reagents and systems. The company focuses on enhancing immunohistochemistry results for pathology practices. Solutions are offered for diagnostic applications across various markets, including the U.S. and international regions. Products such as primary antibodies, detection systems, and instrumentation are provided to support cancer diagnostics and research. The healthcare sector is primarily served with a commitment to quality and regulatory compliance.
- Headquarters Pleasanton, United States
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website dbiosys.com
- Social LinkedIn X Facebook YouTube
- Legal Name Diagnostic Biosystems Inc.
- Date of Incorporation 31 Jul, 2019
- Jurisdiction Secunderabad, Telangana, India
- Indian entity revenue₹5.77 Cr
FY 2025 · +40% YoY
- Indian entity net profit₹5.3 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹10 Lakh
FY 2025 · 2% margin
- Investors
Associated legal entities of Diagnostic BioSystems
Diagnostic BioSystems operates through Diagnostic Biosystems Usa Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Diagnostic Biosystems Usa Private Limited CIN U52609TG2019FTC134481 | Active | 31 Jul 2019 | Secunderabad, Telangana | ₹5.8 Cr | 2 | View details |
Products & Services of Diagnostic BioSystems
Diagnostic BioSystems offers a comprehensive portfolio of products and services, including Primary Antibodies, Detection Systems, and Instrumentation.
Antibodies are provided for diagnostic tissue analysis.
Systems are designed for accurate pathology detection.
Automated systems are offered for slide staining.
Apps and channels of Diagnostic BioSystems
its YouTube channel Diagnostic BioSystems has 117 subscribers and 18 videos.
Videos from Diagnostic BioSystems
The most watched videos on Diagnostic BioSystems's YouTube channel, Diagnostic BioSystems (117 subscribers). Click a video to play it here.
More on Diagnostic BioSystems.
Funding Insights of Diagnostic BioSystems
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Diagnostic BioSystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2015 | Private Equity Round | – | – |
1 investors in total: 1 institutional.
Investors in Diagnostic BioSystems
Diagnostic BioSystems has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Broadoak Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment banking services are offered in the United States. | 2006 | broadoak.com | Bethesda, United States |
Investor details for Diagnostic BioSystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Diagnostic Biosystems Usa Private Limited (Diagnostic BioSystems)
Diagnostic Biosystems Usa Private Limited is the primary company behind Diagnostic BioSystems. The board of Diagnostic Biosystems Usa Private Limited currently have 2 directors; the longest-serving is Bipin Chandra Gupta, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bipin Chandra Gupta DIN 08525036 | Director | 31 Jul 2019 | 7 yrs 3 mo | Diagnostic Biosystems Usa Private Limited |
| Ananda Kumar Meesala DIN 08525037 | Director | 31 Jul 2019 | 7 yrs 3 mo | Diagnostic Biosystems Usa Private Limited |
People of Diagnostic BioSystems
14 people are tracked at Diagnostic BioSystems (8 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Dr. Olga Petrauskene | Chief Operations Officer | Leadership |
Hosna Mujadidi | Head Of Americas' Business Development & Strategic Partnerships | Leadership |
Olga Petrauskene | GM & VP of Business Development | Leadership |
Gerald Weiss | Medical Director | Leadership |
Alejandro Herrera | Director Of Sales Latin America | Leadership |
Marc Key | Chief Scientific Advisor | Leadership |
| President, Asia & Emerging Markets, Sales, Marketing & BD | Leadership | |
| Founder, CEO & CSO | Leadership | |
Kuren Gupta | Global Sales And Marketing Manager | Team |
Wolfgang Vogel | Business Development And Sales Europe | Team |
Mohammad Taher | Manager - Finance & Accounts | Team |
Simi Narindray | Supply Chain Manager | Team |
Chaitanya Paluri | Deputy Manager | Team |
Soniya Mahto | Intern | Team |
Complete people profiles for Diagnostic BioSystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Diagnostic BioSystems
Figures of Diagnostic Biosystems Usa Private Limited, the primary company behind Diagnostic BioSystems, for FY 2025. Revenue was ₹5.77 Cr (+40% year on year). Net profit was ₹5.3 Lakh (1% margin). EBITDA was ₹10 Lakh (2% margin). Revenue has grown at a compounded annual rate of +34% over three years and +121% over five years.
- ₹5.77 CrRevenue · FY 2025 · +40% YoY
- ₹5.3 LakhNet profit · 1% margin
- ₹10 LakhEBITDA · 2% margin
- ₹10 LakhPaid-up capital
- +34%Revenue CAGR, 3 years
- +121%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Diagnostic Biosystems Usa Private Limited are on its company page.
Detailed financial statements for Diagnostic BioSystems
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Diagnostic BioSystems
2 dated milestones of Diagnostic BioSystems across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Diagnostic BioSystems is founded.
- Funding First funding round.
Competitors of Diagnostic BioSystems
Diagnostic BioSystems has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of Diagnostic BioSystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Diagnostic BioSystems
The website of Diagnostic BioSystems (dbiosys.com) receives about 9.7K visits a month and ranks #2,471,921 among all websites worldwide, #3,394 in Biotechnology and Pharmaceuticals.
- Monthly visits9.7K
▲ 8.2% vs previous month
- Unique visitors3.7K
per month
- Global rank#2,471,921
among all websites
- Category rank#3,394
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit1.7
- Average visit16 sec
- DevicesDesktop 31% · Mobile 69%
Websites whose visitors overlap most with Diagnostic BioSystems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| phenopath.com | 100% | 1.4K | #12,857,164 | View details | |
e-immunohistochemistry.info | e-immunohistochemistry.info | 100% | – | ||
himediadownloads.com | himediadownloads.com | 63% | #3,895,832 | – |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Diagnostic BioSystems (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Diagnostic Biosystems
Complete news archive for Diagnostic BioSystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diagnostic BioSystems
Diagnostic BioSystems was founded in 1994 and raised its 1st funding round 21 years after it was founded.
Diagnostic BioSystems is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
The primary company behind Diagnostic BioSystems, Diagnostic Biosystems Usa Private Limited, reported revenue of ₹5.77 Cr for FY 2025, up 40% year on year.
Diagnostic BioSystems is involved in the development and distribution of innovative anatomic pathology reagents and systems. The company focuses on enhancing immunohistochemistry results for pathology practices. Solutions are offered for diagnostic applications across various markets, including the U.S. and international regions. Products such as primary antibodies, detection systems, and instrumentation are provided to support cancer diagnostics and research. The healthcare sector is primarily served with a commitment to quality and regulatory compliance.
Diagnostic BioSystems's top competitors include GenScript, Epitomics and Vector Laboratories.
Diagnostic BioSystems offers Primary Antibodies, Detection Systems, and Instrumentation.
Diagnostic BioSystems has 1 investor. Key investors include Broadoak Capital Partners.
Diagnostic BioSystems operates through Diagnostic Biosystems Usa Private Limited.
The legal entities of Diagnostic BioSystems currently have 2 directors, including Bipin Chandra Gupta, Ananda Kumar Meesala.